We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.56B
AUM Growth
-$316M
Cap. Flow
-$742M
Cap. Flow %
-16.27%
Top 10 Hldgs %
15.49%
Holding
2,634
New
531
Increased
353
Reduced
471
Closed
900

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.7M
3
AMZN icon
Amazon
AMZN
+$22.4M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$21.7M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$18M

Top Sells

Rank Stock Value
1
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$23.1M
2
WMT icon
Walmart Inc
WMT
+$17.7M
3
BURL icon
Burlington
BURL
+$12.7M
4
ALCE
Alternus Clean Energy Inc
ALCE
+$12.1M
5
GILD icon
Gilead Sciences
GILD
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 9.63%
3 Financials 7.8%
4 Industrials 6.22%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRSN
1576
CALL
DELISTED
Mersana Therapeutics
MRSN
$73.4K ﹤0.01%
+892
New +$130K
AGRIW
1577
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$73K ﹤0.01%
321,924
-43,149
-12% -$2.44K
ONFOW icon
1578
Onfolio Holdings Warrant
ONFOW
$72.6K ﹤0.01%
60,000
– –
CDIOW icon
1579
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$730K
$72K ﹤0.01%
60,540
– –
MIST icon
1580
Milestone Pharmaceuticals
MIST
$138M
$71.8K ﹤0.01%
25,176
– –
XFOR icon
1581
X4 Pharmaceuticals
XFOR
$375M
$70K ﹤0.01%
1,203
– –
IMAQR
1582
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$69.4K ﹤0.01%
1,416,063
– –
CIO
1583
DELISTED
City Office REIT
CIO
$67.9K ﹤0.01%
12,197
-10,847
-47% -$59.2K
ATMCR
1584
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
$66.7K ﹤0.01%
438,093
– –
BLNK icon
1585
Blink Charging
BLNK
$74.3M
$66.3K ﹤0.01%
+11,068
New +$76.7K
DNA icon
1586
Ginkgo Bioworks
DNA
$528M
$65.6K ﹤0.01%
882
– –
MCACR
1587
DELISTED
Monterey Capital Acquisition Corporation Rights
MCACR
$65.3K ﹤0.01%
594,000
– –
AUTL
1588
Autolus Therapeutics
AUTL
$397M
$64.8K ﹤0.01%
27,215
– –
POL.WS
1589
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$64.4K ﹤0.01%
140,000
– –
FLFVR
1590
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
$64.3K ﹤0.01%
643,125
– –
CHRS icon
1591
Coherus Oncology
CHRS
$217M
$64K ﹤0.01%
+15,000
New +$88.5K
ASLN
1592
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$60.4K ﹤0.01%
2,069
– –
KOS icon
1593
Kosmos Energy
KOS
$1.6B
$60.3K ﹤0.01%
+10,069
New +$65.6K
BLACR
1594
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$59.5K ﹤0.01%
311,040
– –
LEXXW
1595
DELISTED
Lexaria Bioscience Warrant
LEXXW
$57.7K ﹤0.01%
78,950
– –
EMCGR
1596
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$55.5K ﹤0.01%
346,875
– –
PLTNR
1597
DELISTED
Plutonian Acquisition Corp. Rights
PLTNR
$54.9K ﹤0.01%
322,805
– –
MCAGR
1598
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$54K ﹤0.01%
450,000
– –
GLLIR
1599
DELISTED
Globalink Investment Inc. Rights
GLLIR
$49.4K ﹤0.01%
540,000
-241
-0% -$22
TBMCR
1600
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$47.8K ﹤0.01%
+336,600
New +$49.4K
62 63
64
65 66

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boothbay Fund Management held 2,634 positions worth $4.56B, down 6.5% from $4.87B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $742M in Q2 2023, closing 900 positions and reducing 471 holdings. Its most notable exit was Alternus Clean Energy Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Boothbay Fund Management opened a new position in Indivior Pharmaceuticals worth $21.9M.

  • Boothbay Fund Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 946,208 shares worth $21.9M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $26.9M increase.
  • Boothbay Fund Management's biggest Q2 2023 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $23.1M.
  • Boothbay Fund Management fully exited Alternus Clean Energy Inc in Q2 2023, selling an estimated $12.1M.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $4.56B portfolio in Q2 2023.
  • Boothbay Fund Management opened 531 new positions and closed 900 in Q2 2023.
  • Boothbay Fund Management's portfolio value fell 6.5% quarter-over-quarter to $4.56B.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.